Healthcare Health/Fitness
Serodus merges with Phlogo to expand portfolio
Serodus merges with Phlogo to expand portfolio Serodus ASA announced its plan to merge with Phlogo ApS. The merger would enable Serodus to speed up its commercialization and development strategies.
Pharmstandard offers to buyout shares from rebel shareholders.
OAO Pharmstandard stated they would buyout disgruntled investors at a discount. Russia's biggest pharmaceutical company, OAO Pharmstandard, shrunk the most since May 2009 after its plan to buy out unhappy investors' shares at a discount was revealed.
Vivus Inc signs erectile dysfunction drug deal worth Eur95 million
Vivus Inc signed an impotence drug deal with Italy's Menarini Group for Eur95 million. Vivus Inc announced that it signed a contract with Italy's Menarini Group worth Eur95 million or US$121.
Odyssey sells One Call Care for more than US$1.5 billion - sources
Odyssey Investment Partners LLC was exploring its options on selling One Call Care Management Inc for more than US$1.5 billion.